GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » EV-to-Revenue

Hangzhou AGS Medtech Co (SHSE:688581) EV-to-Revenue : 4.66 (As of May. 27, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hangzhou AGS Medtech Co's enterprise value is ¥2,469.9 Mil. Hangzhou AGS Medtech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥529.9 Mil. Therefore, Hangzhou AGS Medtech Co's EV-to-Revenue for today is 4.66.

The historical rank and industry rank for Hangzhou AGS Medtech Co's EV-to-Revenue or its related term are showing as below:

SHSE:688581' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.7   Med: 8.63   Max: 14.04
Current: 4.64

During the past 7 years, the highest EV-to-Revenue of Hangzhou AGS Medtech Co was 14.04. The lowest was 3.70. And the median was 8.63.

SHSE:688581's EV-to-Revenue is ranked worse than
64.02% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.24 vs SHSE:688581: 4.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Hangzhou AGS Medtech Co's stock price is ¥79.00. Hangzhou AGS Medtech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥9.54. Therefore, Hangzhou AGS Medtech Co's PS Ratio for today is 8.28.


Hangzhou AGS Medtech Co EV-to-Revenue Historical Data

The historical data trend for Hangzhou AGS Medtech Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co EV-to-Revenue Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - - 10.19

Hangzhou AGS Medtech Co Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 12.23 10.44 10.19 4.38

Competitive Comparison of Hangzhou AGS Medtech Co's EV-to-Revenue

For the Medical Devices subindustry, Hangzhou AGS Medtech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou AGS Medtech Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hangzhou AGS Medtech Co's EV-to-Revenue falls into.



Hangzhou AGS Medtech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hangzhou AGS Medtech Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2469.905/529.864
=4.66

Hangzhou AGS Medtech Co's current Enterprise Value is ¥2,469.9 Mil.
Hangzhou AGS Medtech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥529.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou AGS Medtech Co  (SHSE:688581) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hangzhou AGS Medtech Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=79.00/9.544
=8.28

Hangzhou AGS Medtech Co's share price for today is ¥79.00.
Hangzhou AGS Medtech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥9.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou AGS Medtech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou AGS Medtech Co (SHSE:688581) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Hangzhou AGS Medtech Co (SHSE:688581) Headlines

No Headlines